z-logo
open-access-imgOpen Access
A novel biomarker for beryllium sensitization in humans. 1997 annual progress report
Author(s) -
R.J. Albertini
Publication year - 1997
Publication title -
osti oai (u.s. department of energy office of scientific and technical information)
Language(s) - English
Resource type - Reports
DOI - 10.2172/13585
Subject(s) - t cell receptor , beryllium , mutant , in vivo , sensitization , in vitro , hypoxanthine guanine phosphoribosyltransferase , t cell , mutation , microbiology and biotechnology , biology , immunology , gene , cancer research , chemistry , genetics , immune system , organic chemistry
'Overall, this project is designed to identify the beryllium reactive T-cell clones that are proliferating in vivo in individuals sensitized to beryllium. The basic method for identifying such clones is the hprt T-cell mutation assay. The rationale is that in vivo proliferating T-lymphocytes are more likely to undergo hprt mutations and/or be included in hprt mutant fractions of T-cells isolated from peripheral blood. T-lymphocytes isolated as hprt mutants from beryllium sensitized individuals are propagated in vitro and characterized for T-cell receptor (TCR)/3 gene usage patterns and antigen reactivity. Results will be compared with similar characteristics determined for T-cell clones from the same individuals that were developed in vitro from peripheral blood lymphocytes by beryllium stimulation. This research project has several specific aims. Progress for the year 10/1/96 to 9/30/97 is given.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom